Shaw will continue to serve as a special advisor to the Board of Directors, saying “Codexis has a tremendous leadership team in place, and I am pleased to continue supporting the company as it works to commercialize industrial enzymes in the biofuel, chemical, and pharmaceutical industries.”

The news regarding Alan Shaw’s departure follows the resignation of Robert Lawson, Codexis’s former CFO, earlier this month.